1. A nonsynonymous variant I248L of the adenosine A3 receptor is associated with coronary heart disease in a Latvian population
- Author
-
Andrejs Erglis, Linda Tarasova, Raitis Peculis, Gustavs Latkovskis, Janis Klovins, and Valdis Pirags
- Subjects
Nonsynonymous substitution ,Male ,medicine.medical_specialty ,Population ,Coronary Disease ,Biology ,Bioinformatics ,Polymorphism, Single Nucleotide ,Cohort Studies ,Internal medicine ,Databases, Genetic ,Genetics ,medicine ,SNP ,Humans ,education ,Molecular Biology ,Alleles ,education.field_of_study ,Receptor, Adenosine A3 ,Cell Biology ,General Medicine ,Middle Aged ,Adenosine A3 receptor ,Adenosine receptor ,Adenosine ,Latvia ,SNP genotyping ,Endocrinology ,Adenosine Receptor A3 ,Female ,medicine.drug - Abstract
Adenosine plays an important part in the cardiac response to ischemia and reperfusion. The human adenosine receptor A3 (A3R), along with other adenosine receptors, is involved in mediation of those effects. The aim of the study was to ascertain whether the nonsynonymous single-nucleotide polymorphism (SNP) I248L (reference SNP ID: rs35511654) located in the A3R gene is associated with coronary heart disease (CHD). DNA samples from 683 individuals with CHD and from 826 control subjects selected from the Latvian Genome Database were successfully screened for rs35511654 using the TaqMan SNP Genotyping Assay. We observed a significantly decreased frequency of the rs35511654 C allele in a group of CHD patients compared with that in controls (p = 0.009). The association remained significant after adjustment for age, sex, and other nongenetic factors (p = 0.02). These results suggest that A allele of rs35511654 may predispose to CHD.
- Published
- 2011